Click here to sign in with or

by Leigh MacMillan, Vanderbilt University

A new model suggests that a protein involved in the generation of high-density lipoprotein (HDL) works differently than previously thought.

HDL is known as the "good cholesterol" because it moves fat and cholesterol away from artery walls and may help prevent or reduce atherosclerosis and coronary heart disease.

Jere Segrest, MD, Ph.D., professor of Medicine in the Division of Cardiovascular Medicine, and colleagues used computer simulation and cell culture studies to explore how the protein ABCA1 transports fatty molecules from the cell's plasma membrane to HDL. The researchers reported in the journal Nature Communications that ABCA1 extracts phospholipids from the outer surface of the plasma membrane, rather than the inner surface as previously thought.

"Our model of ABCA1 as an extracellular lipid transporter suggests a unique transport mechanism that differs substantially from mechanisms described for other members of this transporter family," Segrest said. "This surprising finding highlights the remarkable diversity in substrate transport within the ABCA transporter superfamily.

"These insights into the mechanism of ABCA1 transport are important because they point towards potential pathways for promoting ABCA1-dependent phospholipid and cholesterol efflux from cholesteryl ester-laden macrophages, which play key roles in all stages of atherosclerotic lesion development," Segrest added.

Hyun Song, Ph.D., research assistant professor of Medicine, used coarse-grained and steered molecular dynamic simulations to show that a "gateway" domain of ABCA1 removes phospholipids from the outer side of the membrane and passes them through a ring-shaped "annulus" domain into a fatty-lined (hydrophobic) tunnel.

Collaborators Chongren Tang, Ph.D., and Jay Heinecke, MD, at the University of Washington, Seattle, engineered mutations in the gateway and annulus domains of the ABCA1 transporter and found that the mutations strongly inhibited lipid export by ABCA1 without affecting transporter cell-surface expression. Explore further Statins may be used to treat primary open-angle glaucoma (POAG) associated with lower ABCA1 expression More information: Jere P. Segrest et al, ABCA1 is an extracellular phospholipid translocase, Nature Communications (2022). DOI: 10.1038/s41467-022-32437-3 Journal information: Nature Communications

More from Biology and Medical

Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use our contact form. For general feedback, use the public comments section below (please adhere to guidelines).

Please select the most appropriate category to facilitate processing of your request

Thank you for taking time to provide your feedback to the editors.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.

Your email address is used only to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Phys.org in any form.

Get weekly and/or daily updates delivered to your inbox. You can unsubscribe at any time and we'll never share your details to third parties.

Medical research advances and health news

The latest engineering, electronics and technology advances

The most comprehensive sci-tech news coverage on the web

This site uses cookies to assist with navigation, analyse your use of our services, collect data for ads personalisation and provide content from third parties. By using our site, you acknowledge that you have read and understand our Privacy Policy and Terms of Use.